Quince Therapeutics, Inc. (QNCX)
(Delayed Data from NSDQ)
$1.71 USD
-0.02 (-1.16%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $1.70 -0.01 (-0.58%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 4/7/25 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.13 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.21 |
Next Year | -0.79 |
EPS (TTM) | -0.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | NA | -1.21 | -0.79 |
# of Estimates | 1 | NA | 1 | 1 |
Most Recent Consensus | -0.19 | NA | -1.21 | -0.79 |
High Estimate | -0.19 | NA | -1.21 | -0.79 |
Low Estimate | -0.19 | NA | -1.21 | -0.79 |
Year ago EPS | -0.21 | -0.26 | -0.84 | -1.21 |
Year over Year Growth Est. | 9.52% | NA | -44.05% | 34.71% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 0 | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | NA | -1.21 | -0.79 |
7 Days Ago | -0.19 | NA | -1.21 | -0.79 |
30 Days Ago | NA | NA | NA | NA |
60 Days Ago | NA | NA | NA | NA |
90 Days Ago | NA | NA | NA | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | NA | -1.21 | -0.79 |
Zacks Consensus Estimate | -0.19 | NA | -1.21 | -0.79 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.13 | -0.18 | -0.26 | -0.21 | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more